Field Trip Health Ltd. (NASDAQ:FTRP) Expected to Report Quarterly Sales of $1.54 Million


Equity research analysts expect Field Trip Health Ltd. (NASDAQ: FTRP – Get Rating) shows current quarter sales of $1.54 million, Zacks reports. Four analysts have made estimates of Field Trip Health’s revenue, with the highest sales estimate of $2.05 million and the lowest estimate of $1.10 million. The company is expected to release its next quarterly earnings report on Monday, January 1.

According to Zacks, analysts expect Field Trip Health to report annual sales of $4.00 million in the current fiscal year, with estimates ranging from $3.58 million to $4.50 million. . For the next fiscal year, analysts expect the company to record sales of $14.91 million, with estimates ranging from $7.90 million to $24.78 million. Zacks Investment Research’s sell calculations are an average average based on a survey of sell-side research analysts who track Field Trip Health.

Separately, Stifel Nicolaus cut his price target on shares of Field Trip Health from C$11.50 to C$10.50 in a Thursday, February 17 research report.

Institutional investors have recently changed their stake in the company. Commonwealth Equity Services LLC bought a new position in shares of Field Trip Health during Q4 for $27,000. Citadel Advisors LLC purchased a new stock position in Field Trip Health during Q3 for $55,000. FinTrust Capital Advisors LLC bought a new position in shares of Field Trip Health during Q3 worth $92,000. Bank of America Corp DE increased its stake in shares of Field Trip Health by 2,422.2% during the 4th quarter. Bank of America Corp DE now owns 22,700 shares of the company worth $55,000 after acquiring an additional 21,800 shares in the last quarter. Finally, Virtu Financial LLC bought a new position in shares of Field Trip Health during Q4 for $61,000. Institutional investors and hedge funds hold 16.84% of the company’s shares.

NASDAQ:FTRP opened at $0.90 on Friday. The company has a quick ratio of 9.41, a current ratio of 9.41 and a leverage ratio of 0.29. Field Trip Health has a 12 month minimum of $0.71 and a 12 month maximum of $6.74. The company has a 50-day simple moving average of $1.12 and a two-hundred-day simple moving average of $1.88.

Field Trip Health Company Profile (Get a rating)

Field Trip Health Ltd. engages in the development and delivery of psychedelic therapies in North America. The company operates Field Trip Health Centers that offer psychedelic therapies; offers Field Trip Digital apps; and Field Trip Discovery, a drug development division developing the next generation of psychedelic molecules.

Recommended Stories

Get a Free Copy of Zacks Research Report on Field Trip Health (FTRP)

For more information on Zacks Investment Research’s research offerings, visit Zacks.com



Get news and reviews for Field Trip Health Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Field Trip Health and related companies with MarketBeat.com’s free daily email newsletter.